Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Interviews With Cannabis Executives, Investors, Celebrities & Policy Makers
02:14pm ET
09/17/2024
Cannabis Investors Should Move Past 'Hopeful Phase' And Focus On Business Fundamentals, Expert Says
Investors urged to shift focus from govt-led momentum to business fundamentals. CEO of Rx Green Tech emphasizes assessing companies' models and ops.
Read More
01:36pm ET
09/17/2024
Federal Rescheduling: What It Could Mean For Cannabis Banking And Capital Markets
Cannabis rescheduling is a hot topic, with Pablo Zuanic discussing its impact on banking and capital markets in a recent interview.
Read More
08:12pm ET
09/16/2024
How This Former DEA Consultant Is Making Craft Cannabis Profitable In New Jersey: A 'Dirt-y' Little Secret
Founded by Lyndsey Shaw, this small, family-run operation has cultivated a reputation for producing top-shelf cannabis in New Jersey.
Read More
03:49pm ET
09/16/2024
More Than $3 Billion At Stake: How Regulatory Red Tape Is Holding Back Australia's Cannabis Legalization
While Australia has legalized medical cannabis, the market is restricted. The strict regulatory framework keeps local cultivators at bay.
Read More
01:46pm ET
09/16/2024
Should Delta-8 THC Be Regulated? 'It's A Total Free-For-All,' Says Industry Expert
Will Muecke, co-founder of Artemis Growth Partners, spoke to Benzinga about the urgent call to tighten controls on synthetic cannabinoids.
Read More
07:58pm ET
09/12/2024
EXCLUSIVE: DEA Stalling Hinders Critical Clinical Trials For Debilitating Conditions, Says MMJ BioPharma CEO
MMJ BioPharma's lawsuit against the DEA delays vital cannabis research for MS and HD treatments. Could this legal battle reshape policy?
Read More
01:42pm ET
09/12/2024
Expert Calls For A United Hemp And Cannabis Front, 'Industries Should Collaborate' And Push For Federal Rules
Jim Higdon calls for collaboration between cannabis and hemp industries as California's crackdown on hemp products sparks reg debate
Read More